RK

Ramesh Kamsu

Director Director DIN 08822239
DIN 08822239 First appointment Aug 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2020
Shareholding value Locked Premium profile

About Ramesh Kamsu

Ramesh Kamsu has 6 years in corporate governance. Formerly with 1 company, such as Lian Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08822239
Primary Designation Director
First Appointment 06 Aug 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Lian Pharmaceuticals Private Limited U74999KA2017PTC102816
Director 06 Aug 2020 2017 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lian Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramesh Kamsu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Kamsu

Ramesh Kamsu has 6 years in corporate governance. Formerly with 1 company, such as Lian Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ramesh Kamsu is associated with 0 companies as a director.

Ramesh Kamsu has expertise in General Business.

Ramesh Kamsu has 6 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available